ESTIMATED SAVINGS IN MEDICAL COSTS WHEN NEW ORAL ANTICOAGULANTS ARE USED FOR THE TREATMENT OF PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION AND VENOUS THROMBOEMBOLISM VS. WARFARIN IN THE U.S

被引：1

作者：

Amin, A. ^{[1
]}

Bruno, A. ^{[2
]}

Trocio, J. ^{[3
]}

Lin, J. ^{[4
]}

Lingohr-Smith, M. ^{[4
]}

机构：

[1] Univ Calif Irvine, Irvine, CA USA

[2] Bristol Myers Squibb Co, Plainsboro, NJ USA

[3] Pfizer, New York, NY USA

[4] Novosys Hlth, Green Brook, NJ USA

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 03期

关键词：

D O I：

10.1016/j.jval.2015.03.802

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PCV49

引用

页码：A138 / A138

页数：1

共 50 条

[41] A CONSERVATIVE APROACH TO ASSESS WARFARIN TIME-IN-THERAPEUTIC RANGES AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS IN AN INTEGRATED HEALTHCARE DELIVERY SYSTEM SETTING IN THE U.S
Deitelzweig, S.
Evans, M.
Hillson, E.
Trocio, J.
Bruno, A.
Tan, W.
Lingohr-Smith, M.
Lin, J.
VALUE IN HEALTH, 2015, 18 (03) : A146 - A146
[42] Double blind vs. open design on treatment effect of new oral anticoagulants in atrial fibrillation: a meta-analysis
Lega, J. C.
Mismetti, P.
Fassier, T.
Bertoletti, L.
Cucherat, M.
Vital-Durand, D.
Laporte, S.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 17 - 17
[43] Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature
Dentali, Francesco
Sironi, Anna Paola
Gianni, Monica
Orlandini, Francesco
Guasti, Luigina
Grandi, Anna Maria
Franchini, Massimo
Ageno, Walter
Squizzato, Alessandro
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (07): : 774 - 787
[44] Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy - Warfarin vs. Direct Oral Anticoagulants -
Kawabata, Mihoko
Goya, Masahiko
Sasaki, Takeshi
Maeda, Shingo
Shirai, Yasuhiro
Nishimura, Takuro
Yoshitake, Takakatsu
Shiohira, Shinya
Isobe, Mitsuaki
Hirao, Kenzo
CIRCULATION JOURNAL, 2017, 81 (05) : 645 - 651
[45] Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis -
Senoo, Keitaro
Lau, Yee Cheng
Dzeshka, Mikhail
Lane, Deirdre
Okumura, Ken
Lip, Gregory Y. H.
CIRCULATION JOURNAL, 2015, 79 (02) : 339 - 345
[46] Comparing total medical expenditure between patients receiving direct oral anticoagulants vs warfarin for the treatment of atrial fibrillation: evidence from VA-Medicare dual enrollees
Wong, Edwin S.
Done, Nicolae
Zhao, Molly
Woolley, Adam B.
Prentice, Julia C.
Mull, Hillary J.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (08): : 1056 - 1066
[47] Response to Letter Regarding Article, "New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation"
Ansell, Jack
CIRCULATION, 2012, 126 (04) : E46 - E46
[48] COMPARISON OF BLEEDING AND TREATMENT PERSISTENCE AMONG NEW USERS OF NOVEL ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
Lamberts, Morten
Harboe, Louise
Lefevre, Cinira
Evans, David
Gislason, Gunnar
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 887 - 887
[49] The association of non-vitamin K antagonist oral anticoagulants vs. warfarin and the risk of fractures for patients with atrial fibrillation: a systematic review and meta-analysis
Yang, Nana
Zhao, Ying
Bai, Zhaohui
Chen, Haokun
Ning, Haoyu
Zou, Meijuan
Cheng, Gang
ACTA CARDIOLOGICA, 2023, 78 (03) : 298 - 310
[50] Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four post-hoc Analyses of Randomized Clinical Trials
Liu, Fuwei
Wang, Yunhong
Luo, Jun
Huang, Lin
Zhu, Wengen
Yin, Kang
Xue, Zhengbiao
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9

← 1 2 3 4 5 →